LYVA Labs
- Company typePrivate
- Founded2021
- HeadquartersLiverpool, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
LYVA Labs firmographics
Firmographics- Name
- LYVA Labs
- Legal name
- LCR Ventures Ltd
- Website
- https://lyvalabs.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
LYVA Labs industry classification
Industry- Product category
- Startup Investment & Innovation Support
- NAICS
- Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Research & Science Grantmaking Foundations (BPAGAKAI)
- akta.pro secondary industries
- Health & Medical Research Grantmaking Foundations (BPAGAKAL), Research Administration & Grants Management Support (Pre/Post-Award, Compliance) (EDAEALAO), Healthcare Access & Life Sciences Impact Funds (FSANAJAI), Workforce Development & Training Grants (Public Health) (HLAJALAM)
Keywords
Where LYVA Labs is headquartered
LocationHeadquarters
- HQ city
- Liverpool
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
LYVA Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Grant-Funded Operations: LYVA Labs operates as a publicly-funded innovation catalyst supported by the Liverpool City Region Combined Authority and UKRI/Innovate UK. The organization deploys investment capital and grant facilitation services at no cost to early-stage companies, generating social and economic returns for the region rather than commercial revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Free support programs for qualifying early-stage companies |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
LYVA Labs product offering
Product offeringCore offering
LYVA Labs is Liverpool City Region's innovation investment company, providing pre-seed investment capital alongside structured Incubator (six-month) and Accelerate (nine-month) programmes, the Future Medicines Accelerator for advanced therapeutics and radiopharmaceuticals SMEs, R&D Partner Grant Funding matching up to £15,000 pound-for-pound, Consortia Building services for large-scale collaborations, and the Clean Tech for Health Fund offering up to £100,000. Its core focus sectors are health and life sciences, deep tech, and clean tech, and all services are delivered free of charge to qualifying early-stage startups and SMEs through public funding.
Product overview
LYVA Labs is Liverpool City Region's innovation investment company that operates as a platform of interconnected support services rather than a single software product. The core offering comprises an Incubator Programme (6-month early-stage support with £25k investment), Accelerate Programme (9-month scale-up support), and Future Medicines Accelerator (Innovate UK-funded sector-specific programme). These are complemented by the Investment Fund (pre-seed capital for health, deep tech, and clean tech startups), R&D Partner Grant Funding (pound-for-pound matching grants up to £15k), Consortia Building services, and the Clean Tech for Health Fund (up to £100k pre-seed for sustainability-health innovations). The Entrepreneur Club provides ongoing alumni support. All programmes are delivered in partnership with regional institutions including Liverpool City Region Combined Authority, UKRI, Innovate UK, universities, and industry partners.
Differentiator
Problem solved
Functional benefit
Brands
- Incubator Programme: Early-stage support for founders developing innovative ideas into viable, investable businesses
- Accelerate Programme
- Future Medicines
- R&D Funding
- Consortia
- Clean Tech for Health Fund
Products and services
- Incubator Programme Six-month early-stage startup support programme offering £25,000 investment or consultancy budget, personalised account management, expert-led workshops, bespoke mentoring, grant application assistance, and concluding Demo Day investor pitches. For early-stage founders developing innovative ideas into viable, investable businesses in health/life sciences, deep tech, or clean tech.
- Accelerate Programme Nine-month intensive programme providing tailored expert support, guidance, and strategic insight for startups and SMEs ready to scale, secure investment and grow faster. For Liverpool City Region companies in health/life sciences, deep tech, or clean tech.
- Future Medicines Accelerator Six-month Innovate UK Biomedical Catalyst-funded accelerator programme for SMEs in advanced therapeutics and radiopharmaceuticals, providing tailored guidance, funded technical support, and market potential assessment to prepare for securing funding.
- Pre-seed Investment Fund Pre-seed investment capital for startups in health and life sciences, deep tech, or clean tech in Liverpool City Region, providing funding alongside business support and mentorship.
- Clean Tech for Health Fund Pre-seed investment fund offering up to £100,000 for startups developing innovations that deliver both environmental sustainability and health benefits, funded under the Liverpool City Region Innovation Zone programme.
- R&D Partner Grant Funding R&D grant funding supporting businesses across net zero, advanced manufacturing, life sciences, and digital technologies to foster new expert partnerships and access funding. Matches investment pound-for-pound up to 50% of eligible costs, up to £15,000.
- Consortia Building Service for developing large-scale collaborations between established businesses and knowledge base institutions to exploit Liverpool City Region's unique capabilities and assets.
- Entrepreneur Club Alumni initiative providing ongoing support to founders beyond LYVA Labs' existing programmes through small, expert-led sessions focused on scaling innovative businesses, funding, investor access and sector-specific expertise.
Quantifiable outcome
- 35 early-stage companies invested in
- +3 more outcomes
Companies that use LYVA Labs
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
LYVA Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
LYVA Labs partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Centre for Process Innovation (CPI)coreProvides access to technical infrastructure and R&D capabilities for portfolio companies, particularly in the formulation, biotech, and medtech sectors.
- University of LiverpoolcoreAcademic partner providing research expertise, talent pipeline, and technology transfer opportunities for startups in the LYVA Labs portfolio.
- Sci-Tech DaresburycoreNational Science and Innovation Campus providing access to advanced facilities, expertise, and cluster benefits for high-tech startups in the LYVA Labs ecosystem.
- Science and Technology Facilities Council (STFC)coreGovernment body providing access to scientific facilities, technical expertise, and innovation support for portfolio companies requiring specialized R&D infrastructure.
- Infection Innovation Consortium (iiCON)minorInfection-focused innovation consortium providing specialized sector expertise and network access for health and life sciences portfolio companies.
- BionowminorNorthern England biotech and biomedical network providing sector-specific support and peer connections for life sciences startups.
- Barclays Eagle LabsminorBanking sector innovation program providing co-working space access and startup ecosystem connections for portfolio companies.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
LYVA Labs competitors and assessment
Company assessmentBroad incumbents
- Centre for Process Innovation (CPI): UK Catapult providing R&D infrastructure and commercialisation support for advanced manufacturing, life sciences, and energy sectors. Named LYVA Labs partner; broader scope and national footprint but overlapping mission of supporting innovative SMEs.
- Innovate UK: UK's national innovation agency providing grant funding and programmes to UK businesses. A major upstream partner/fund provider to LYVA Labs rather than a competitor; comparable as a UK innovation funding ecosystem actor.
Regional players
- Scottish Enterprise: Scotland's national economic development agency running innovation, investment, and business support programmes including equity investment funds for early-stage Scottish companies. Comparable public-sector regional innovation investment vehicle, but Scotland-focused rather than North West England.
Direct peers
- Cambridge Innovation Capital: Cambridge University-focused deep tech and life sciences investor. Similar thesis of commercialising research from a specific regional university ecosystem; larger and more established than LYVA Labs but a useful strategic peer.
- Bionow: Northern England membership organisation for biomedical and life sciences companies providing networking, specialist support, and acceleration. Named LYVA Labs partner; comparable Northern England life sciences cluster support organisation.
- Deepbridge Capital: UK early-stage investor focused on life sciences, technology, and sustainable technology. Named LYVA Labs co-investment partner; comparable pre-seed/seed life sciences investment focus with EIS fund structures for high-growth UK SMEs.
- Northern Gritstone: Manchester-based investment firm backing university spinouts in the North of England across deep tech, life sciences, and clean tech. Directly comparable: co-invested with LYVA Labs in Plasma Fresh, similar regional UK university spinout thesis, and overlapping fund partners (e.g., Deepbridge Capital).
- Oxford Sciences Innovation: University of Oxford-affiliated investor in deep tech and life sciences spinouts. Comparable in mission (commercialising university research) but operates at much larger scale; useful benchmark for institutional-grade UK university spinout investment.
- BioCity (now part of Pioneer Group): UK-based life sciences incubator and investor that runs accelerator programmes, provides lab infrastructure, and invests in early-stage biotech/health startups. Closely comparable in early-stage life sciences incubation model and accelerator programmes.
- Bruntwood SciTech: UK innovation district operator and investor providing lab infrastructure, business support, and growth capital to science and technology businesses. Comparable regional innovation platform model, though operating at significantly larger scale across multiple UK cities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
LYVA Labs social profiles
Digital presenceLYVA Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
LYVA Labs leadership team
Management profileNumber of profiles
Profiles12 records
LYVA Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LYVA Labs M&A and investment
M&A and investmentM&A
Investments11 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LYVA Labs
What does LYVA Labs do?
LYVA Labs is Liverpool City Region's innovation investment company, providing pre-seed investment capital alongside structured Incubator (six-month) and Accelerate (nine-month) programmes, the Future Medicines Accelerator for advanced therapeutics and radiopharmaceuticals SMEs, R&D Partner Grant Funding matching up to £15,000 pound-for-pound, Consortia Building services for large-scale collaborations, and the Clean Tech for Health Fund offering up to £100,000. Its core focus sectors are health and life sciences, deep tech, and clean tech, and all services are delivered free of charge to qualifying early-stage startups and SMEs through public funding.
Is LYVA Labs a public or private company?
LYVA Labs is a private company. It is classified as state government owned and is currently operating.
When was LYVA Labs founded?
LYVA Labs was founded in 2021. It employs 11 to 50 people.
Where is LYVA Labs based?
LYVA Labs is headquartered in Liverpool, United Kingdom, in the Europe region.
How does LYVA Labs make money?
One revenue line is on record: grant-Funded Operations.
Who are LYVA Labs's main competitors?
Broad incumbents on record are Centre for Process Innovation (CPI) and Innovate UK. Scottish Enterprise is listed as a regional player. Direct peers are Cambridge Innovation Capital, Bionow, Deepbridge Capital, Northern Gritstone, Oxford Sciences Innovation, BioCity (now part of Pioneer Group) and Bruntwood SciTech.
Does LYVA Labs have an API?
No public API is recorded for LYVA Labs.
What industry is LYVA Labs in?
LYVA Labs's product category is Startup Investment & Innovation Support. Its primary akta.pro industry code is BPAGAKAI, Research & Science Grantmaking Foundations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 6282.